KLF17 and neoplasm: Downregulation of MYC and ITGA6 and upregulation of KLF17, a negative regulator of the epithelial-mesenchymal transition (EMT) and metastasis in breast cancer13, are consistent with the anti-tumor effects of triptonide in TNBC cells.